718 related articles for article (PubMed ID: 29929592)
1. Prurigo Nodularis and Its Management.
Zeidler C; Yosipovitch G; Ständer S
Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
[TBL] [Abstract][Full Text] [Related]
2. Prurigo Nodularis Management.
Tsianakas A; Zeidler C; Ständer S
Curr Probl Dermatol; 2016; 50():94-101. PubMed ID: 27578077
[TBL] [Abstract][Full Text] [Related]
3. Chronic Prurigo of Nodular Type: A Review.
Zeidler C; Tsianakas A; Pereira M; Ständer H; Yosipovitch G; Ständer S
Acta Derm Venereol; 2018 Feb; 98(2):173-179. PubMed ID: 29135018
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of evidence-based treatments for prurigo nodularis.
Qureshi AA; Abate LE; Yosipovitch G; Friedman AJ
J Am Acad Dermatol; 2019 Mar; 80(3):756-764. PubMed ID: 30261199
[TBL] [Abstract][Full Text] [Related]
5. Prurigo nodularis: a review.
Lee MR; Shumack S
Australas J Dermatol; 2005 Nov; 46(4):211-18; quiz 219-20. PubMed ID: 16197418
[TBL] [Abstract][Full Text] [Related]
6. Prurigo nodularis: Pathogenesis and management.
Williams KA; Huang AH; Belzberg M; Kwatra SG
J Am Acad Dermatol; 2020 Dec; 83(6):1567-1575. PubMed ID: 32461078
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Management of Neuropathic Itch.
Rosen JD; Fostini AC; Yosipovitch G
Dermatol Clin; 2018 Jul; 36(3):213-224. PubMed ID: 29929594
[TBL] [Abstract][Full Text] [Related]
8. Prurigo nodularis: an update on etiopathogenesis and therapy.
Fostini AC; Girolomoni G; Tessari G
J Dermatolog Treat; 2013 Dec; 24(6):458-62. PubMed ID: 23767411
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis of Prurigo nodularis--'Super-Itch' in exploration.
Zeidler C; Ständer S
Eur J Pain; 2016 Jan; 20(1):37-40. PubMed ID: 26416433
[TBL] [Abstract][Full Text] [Related]
10. Prurigo nodularis: a benign dermatosis derived from a persistent pruritus.
Vaidya DC; Schwartz RA
Acta Dermatovenerol Croat; 2008; 16(1):38-44. PubMed ID: 18358109
[TBL] [Abstract][Full Text] [Related]
11. [Chronic prurigo].
Pereira MP; Nau T; Zeidler C; Ständer S
Hautarzt; 2018 Apr; 69(4):321-330. PubMed ID: 29568995
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulating Agents as Antipruritics.
Erickson S; Nahmias Z; Rosman IS; Kim BS
Dermatol Clin; 2018 Jul; 36(3):325-334. PubMed ID: 29929604
[TBL] [Abstract][Full Text] [Related]
13. Itch Management: Treatments under Development.
Pereira MP; Ständer S
Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
[TBL] [Abstract][Full Text] [Related]
14. [Update on the treatment of chronic prurigo].
Zeidler C; Pereira MP; Ständer S
Dermatologie (Heidelb); 2022 Aug; 73(8):614-619. PubMed ID: 35925236
[TBL] [Abstract][Full Text] [Related]
15. Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.
Yook HJ; Lee JH
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791201
[TBL] [Abstract][Full Text] [Related]
16. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
[TBL] [Abstract][Full Text] [Related]
17. Chronic hemicorporal prurigo related to a posttraumatic Brown-Séquard syndrome.
Thielen AM; Vokatch N; Borradori L
Dermatology; 2008; 217(1):45-7. PubMed ID: 18367840
[TBL] [Abstract][Full Text] [Related]
18. Treatment of prurigo nodularis with topical capsaicin.
Ständer S; Luger T; Metze D
J Am Acad Dermatol; 2001 Mar; 44(3):471-8. PubMed ID: 11209117
[TBL] [Abstract][Full Text] [Related]
19. [Prurigo nodularis: its association with dermatoses and systemic disorders].
Mettang T; Vonend A; Raap U
Hautarzt; 2014 Aug; 65(8):697-703. PubMed ID: 25113328
[TBL] [Abstract][Full Text] [Related]
20. Chronic Pruritus in the Geriatric Population.
Cao T; Tey HL; Yosipovitch G
Dermatol Clin; 2018 Jul; 36(3):199-211. PubMed ID: 29929593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
